Episurf Medical (Nasdaq: EPIS B) today announces that the poster presentation “Clinical results of a patient-specific mini-metal implant for focal cartilage lesions in the knee after 5 years” by Dr. med. Johannes Holz from Orthocentrum, Park-Klinik Manhagen, Hamburg, Germany, et al. which was presented at the 3rd World Arthroplasty Congress, is now available through Episurf Medical’s website. The poster presentation focuses on clinical results from the use of the Episealer® knee implant with a follow-up of up to 5 years (15 patients with 5 years’ results). The poster concludes that “This alternative (Episealer®) can avoid early unicompartmental or total knee arthroplasty while maintaining the biomechanics of articulation and replacing chondral defects”.

“Positive 5-years’ results is a tremendous achievement. However, we are trying to be cautious as we look forward to seeing 5-years results published and in larger cohorts. That said, this is the second study from which we have seen strong preliminary results of up to 5-years, which is very comforting,” says Pål Ryfors, CEO Episurf Medical.